Iridex (IRIX) Total Non-Current Liabilities (2011 - 2026)
Iridex (IRIX) posted Total Non-Current Liabilities of $23.1 million for Q3 2026, little changed on a QoQ basis from $23.1 million in Q2 2026, and down 8.31% year-over-year from $25.2 million in Q3 2025.
Analysis
Iridex (IRIX) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
Iridex has reported Total Non-Current Liabilities for 16 years, with the latest figure at $23.1 million in Q3 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 8.31% year-over-year to $23.1 million in Q3 2026; TTM through Jul 2026 was $23.1 million, a 8.31% decrease from a year earlier, with the FY2026 full-year figure at $23.8 million, down 10.78% from the prior year.
- Total Non-Current Liabilities was $23.1 million for Q3 2026 at Iridex, roughly flat from $23.1 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $27.3 million in Q1 2024, with the low at $22.7 million in Q3 2023.
- Average Total Non-Current Liabilities over 5 years is $25.2 million, with a median of $25.2 million recorded in 2025.
- The sharpest annual moves came in 2022 and 2023: Total Non-Current Liabilities soared 140.73% in 2022, then decreased 15.1% in 2023.
- Over 5 years, Total Non-Current Liabilities stood at $25.0 million in 2022, then dropped by 0.81% to $24.8 million in 2023, then gained by 7.98% to $26.7 million in 2024, then declined by 12.6% to $23.4 million in 2025, then retreated by 1.0% to $23.1 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $23.1 million (Q3 2026), $23.1 million (Q2 2026), and $23.8 million (Q1 2026), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 40.46 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 21.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 17.56 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 2.57 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 6.34 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 3.68 Bn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Iridex | 11.85 Mn | 7.17 Mn | 4.30 Mn | 23.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 4, 2026 | 23.12 Mn |
| Apr 4, 2026 | 23.10 Mn |
| Jan 3, 2026 | 23.84 Mn |
| Sep 27, 2025 | 23.36 Mn |
| Jun 28, 2025 | 25.22 Mn |
| Mar 29, 2025 | 27.09 Mn |
| Dec 28, 2024 | 26.72 Mn |
| Sep 28, 2024 | 27.21 Mn |
| Jun 29, 2024 | 26.70 Mn |
| Mar 30, 2024 | 27.30 Mn |
| Dec 30, 2023 | 24.75 Mn |
| Sep 30, 2023 | 22.75 Mn |
| Jul 1, 2023 | 23.35 Mn |
| Apr 1, 2023 | 24.97 Mn |
| Dec 31, 2022 | 24.95 Mn |
| Oct 1, 2022 | 26.79 Mn |
| Jul 2, 2022 | 26.14 Mn |
| Apr 2, 2022 | 26.62 Mn |
| Jan 1, 2022 | 25.33 Mn |
| Oct 2, 2021 | 25.16 Mn |